Clinical Trials Directory

Trials / Sponsors / Stichting European Myeloma Network

Stichting European Myeloma Network

Network · 12 registered clinical trials2 currently recruiting.

StatusTrialPhaseStarted
RecruitingUse of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
Smoldering Multiple Myeloma
Phase 22024-05-14
RecruitingPhase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With
Multiple Myeloma
Phase 22023-11-23
Active Not RecruitingA Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleuce
Multiple Myeloma
Phase 32023-10-10
CompletedA Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis
AL Amyloidosis
Phase 22021-02-26
Active Not RecruitingIberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
Multiple Myeloma
Phase 22021-02-22
CompletedCOVID-19 Infection and Multiple Myeloma
Multiple Myeloma, Covid19, Corona Virus Infection
2020-07-01
Active Not RecruitingDaratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma
Multiple Myeloma, Extramedullary Plasmacytoma
Phase 22019-10-31
CompletedA Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis
Light Chain (AL) Amyloidosis, Stage 3B
Phase 22019-09-23
Active Not RecruitingDaratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenanc
Multiple Myeloma
Phase 22019-04-16
Active Not RecruitingDaratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexame
Multiple Myeloma
Phase 32018-12-14
CompletedComparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/Dex
Multiple Myeloma
Phase 32017-06-14
CompletedCarfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma
Multiple Myeloma
Phase 1 / Phase 22014-04-01